Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Cardiology and Cardiovascular Medicine journal rankings 2024
289 ranked journals · Subfield in Medicine
Cardiology and Cardiovascular Medicine has 289 ranked journals in 2024. The median journal has an OJR of 0.69, below the world average of 1.00, down 0.01 on 2023; Q1 starts at OJR 1.21. The top three are Circulation, European Heart Journal, and Journal of the American College of Cardiology.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
289 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1CirculationLippincott Williams & Wilkins · United States | 7.85Q1 | 22.79 2.47 up from 2023 | 1,425 | 6% | — | ||
2European Heart JournalOxford University Press · United Kingdom | 5.80Q1 | 13.82 2.69 down from 2023 | 1,955 | 53% | $5,922 | ||
3Journal of the American College of CardiologyElsevier BV · United States | 5.35Q1 | 14.34 1.13 up from 2023 | 1,622 | 99% | $7,166 | ||
4Nature Reviews CardiologyNature Portfolio · United Kingdom | 4.20Q1 | 15.67 0.61 down from 2023 | 468 | 26% | — | ||
5Cardiovascular ResearchOxford University Press · United Kingdom | 3.48Q1 | 11.99 2.76 up from 2023 | 607 | 82% | $5,329 | ||
6JAMA CardiologyAmerican Medical Association · United States | 3.09Q1 | 7.20 0.62 down from 2023 | 738 | 57% | — | ||
7Circulation Arrhythmia and ElectrophysiologyLippincott Williams & Wilkins · United States | 2.77Q1 | 7.56 0.91 up from 2023 | 305 | 46% | — | ||
8Trends in Cardiovascular MedicineElsevier BV · United States | 2.76Q1 | 7.76 0.50 up from 2023 | 144 | 39% | $4,740 | ||
9Annual Review of MedicineAnnual Reviews · United States | 2.75Q1 | 14.80 1.91 down from 2023 | 111 | 100% | — | ||
10HypertensionLippincott Williams & Wilkins · United States | 2.66Q1 | 7.60 0.16 up from 2023 | 938 | 28% | — | ||
11Medical Clinics of North AmericaElsevier BV · United States | 2.54Q1 | 4.47 0.42 down from 2023 | 256 | 9% | $3,350 | ||
12JACC CardioOncologyOAElsevier BV · United States | 2.52Q1 | 7.03 0.12 down from 2023 | 273 | 100% | $4,200 | ||
13Basic Research in CardiologySpringer Nature · Germany | 2.49Q1 | 8.34 0.44 up from 2023 | 171 | 77% | $4,990 | ||
14JAMA Internal MedicineAmerican Medical Association · United States | 2.48Q1 | 6.77 1.03 up from 2023 | 1,233 | 43% | — | ||
15European Journal of Heart FailureElsevier BV · Netherlands | 2.42Q1 | 6.97 1.12 down from 2023 | 934 | 89% | $5,300 | ||
16EP EuropaceOxford University Press · United Kingdom | 2.37Q1 | 7.28 0.38 down from 2023 | 879 | 100% | $4,909 | ||
17Circulation Cardiovascular InterventionsLippincott Williams & Wilkins · United States | 2.34Q1 | 6.18 0.92 up from 2023 | 359 | 38% | — | ||
18Progress in Cardiovascular DiseasesElsevier BV · United States | 2.34Q1 | 6.82 1.90 up from 2023 | 254 | 35% | $4,130 | ||
19European Heart Journal - Cardiovascular ImagingOxford University Press · United Kingdom | 2.24Q1 | 5.56 0.71 down from 2023 | 500 | 59% | $5,203 | ||
20American Journal of Preventive CardiologyOAElsevier BV · Netherlands | 2.21Q1 | 6.12 1.05 up from 2023 | 204 | 100% | $1,900 | ||
21Circulation Cardiovascular Quality and OutcomesLippincott Williams & Wilkins · United States | 2.18Q1 | 5.49 0.46 up from 2023 | 313 | 53% | — | ||
22Current Hypertension ReportsSpringer Science+Business Media · United States | 2.17Q1 | 6.30 1.07 up from 2023 | 163 | 58% | $4,590 | ||
23JACC Heart FailureElsevier BV · Netherlands | 2.14Q1 | 5.45 0.22 down from 2023 | 585 | 96% | $5,000 | ||
24Journal of the American Heart AssociationOAWiley · United States | 2.08Q1 | 5.40 0.02 down from 2023 | 2,996 | 100% | $3,810 | ||
25Cardiac failure reviewOAUnited Kingdom | 2.08Q1 | 6.47 1.72 up from 2023 | 70 | 100% | $2,146 | ||
26EuroInterventionEuropean Association of Percutaneous Cardiovascular Interventions · France | 2.07Q1 | 5.40 0.61 up from 2023 | 671 | 100% | — | ||
27JACC. Cardiovascular imagingElsevier BV · Netherlands | 2.05Q1 | 5.99 0.71 up from 2023 | 860 | 100% | $5,000 | ||
28European Journal of Preventive CardiologyOxford University Press · United Kingdom | 2.02Q1 | 5.34 0.16 up from 2023 | 661 | 74% | $3,792 | ||
29Circulation Heart FailureLippincott Williams & Wilkins · United States | 1.90Q1 | 5.46 0.14 down from 2023 | 431 | 53% | — | ||
30JACC. Clinical electrophysiologyElsevier BV · United States | 1.83Q1 | 4.42 0.03 up from 2023 | 757 | 98% | $5,000 | ||
31JACC Basic to Translational ScienceOAElsevier BV · United States | 1.75Q1 | 4.56 1.53 down from 2023 | 378 | 100% | $4,750 | ||
32JACC: Cardiovascular InterventionsElsevier BV · United States | 1.73Q1 | 4.29 0.07 down from 2023 | 1,490 | 99% | $5,000 | ||
33Current Heart Failure ReportsSpringer Science+Business Media · United States | 1.62Q1 | 4.30 0.58 down from 2023 | 132 | 47% | $4,490 | ||
34Current Cardiology ReportsSpringer Science+Business Media · United States | 1.58Q1 | 4.11 0.12 up from 2023 | 558 | 33% | $4,490 | ||
35Circulation Genomic and Precision MedicineWolters Kluwer · United States | 1.57Q1 | 3.83 0.84 down from 2023 | 237 | 68% | — | ||
36Clinical HypertensionOABioMed Central · United Kingdom | 1.54Q1 | 4.45 1.10 up from 2023 | 99 | 100% | $0 listed | ||
37Mayo Clinic ProceedingsElsevier BV · United Kingdom | 1.54Q1 | 3.31 0.66 down from 2023 | 949 | 74% | $3,900 | ||
38European Heart Journal - Quality of Care and Clinical OutcomesOxford University Press · United Kingdom | 1.52Q1 | 4.32 0.23 up from 2023 | 234 | 67% | $4,591 | ||
39Vascular Health and Risk ManagementOADove Medical Press · New Zealand | 1.51Q1 | 3.52 0.02 down from 2023 | 250 | 100% | $2,320 | ||
40Heart Failure ReviewsSpringer Science+Business Media · United States | 1.51Q1 | 4.88 0.73 down from 2023 | 293 | 38% | $3,090 | ||
41Journal of HypertensionLippincott Williams & Wilkins · United Kingdom | 1.49Q1 | 5.03 2.19 up from 2023 | 822 | 8% | — | ||
42JACC AsiaOAElsevier BV · United States | 1.48Q1 | 3.41 0.10 up from 2023 | 267 | 100% | $4,084 | ||
43Circulation Cardiovascular ImagingLippincott Williams & Wilkins · United States | 1.47Q1 | 3.88 0.44 up from 2023 | 389 | 33% | — | ||
44European Cardiology ReviewOARadcliffe Publishing · United Kingdom | 1.46Q1 | 3.89no change | 128 | 100% | $2,146 | ||
45European Heart Journal - Digital HealthOAOxford University Press · United Kingdom | 1.44Q1 | 4.77 0.62 up from 2023 | 225 | 100% | $3,725 | ||
46Global HeartOAElsevier BV · United Kingdom | 1.44Q1 | 3.97 0.24 up from 2023 | 241 | 100% | $3,300 | ||
47Journal of the Renin-Angiotensin-Aldosterone SystemSAGE Publishing · United Kingdom | 1.43Q1 | 4.88 2.06 up from 2023 | 57 | 100% | $4,150 | ||
48Arrhythmia & Electrophysiology ReviewOARadcliffe Publishing · United Kingdom | 1.42Q1 | 4.24 0.99 up from 2023 | 91 | 100% | $2,146 | ||
49American Heart JournalElsevier BV · United States | 1.41Q1 | 3.84 0.12 up from 2023 | 573 | 49% | $4,070 | ||
50Radiology Cardiothoracic ImagingRadiological Society of North America · United States | 1.41Q1 | 3.27 0.60 down from 2023 | 224 | 95% | — |
Subfields of Medicine, with Cardiology and Cardiovascular Medicine highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
47 additional Cardiology and Cardiovascular Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 289
- Window papers (baseline)
- 137,659 +6.5% from indicator year 2021
- Median OJR
- 0.691 +2.4% from indicator year 2021
- Rising journals (2025)
- 29
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 100 | 111 | 124 | 128 | 136 | 139 | 150 | 162 | 173 | 184 | 190 | 200 | 209 | 218 | 227 | 238 | 248 | 266 | 280 | 290 | 294 | 297 | 296 | 293 | 289 | 287 | |
| Window papers (baseline) | 38,504 | 43,221 | 45,691 | 48,567 | 50,285 | 54,819 | 60,687 | 66,011 | 71,206 | 78,674 | 83,572 | 88,872 | 90,962 | 95,515 | 101,247 | 105,471 | 109,295 | 111,295 | 114,960 | 118,626 | 123,446 | 129,250 | 135,096 | 137,746 | 137,659 | 138,818 | |
| Median OJR | 0.48 | 0.51 | 0.53 | 0.66 | 0.65 | 0.717 | 0.6771 | 0.684 | 0.666 | 0.74 | 0.79 | 0.80 | 0.77 | 0.78 | 0.76 | 0.73 | 0.724 | 0.682 | 0.668 | 0.678 | 0.718 | 0.674 | 0.6769 | 0.70 | 0.691 | 0.694 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.